Osteomimetic matrix components alter cell migration and drug response in a 3D tumour-engineered osteosarcoma model

[Display omitted] Osteosarcoma management continues to lack the appropriate prognostic tools to assign personalised treatment. This leaves non-responders to standard care vulnerable to recurring disease and pulmonary metastases. Developing 3D in vitro disease models to serve as a test bed for person...

Ausführliche Beschreibung